Zoetis Inc. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
Zoetis Inc. (ZTS) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $4.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2025-02-13
- Zoetis Inc. noncontrolling interest, decrease from redemptions or purchase of interests for the quarter ending 2020-12-31 was $0.00.
- Zoetis Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2024 was $4.00M.
- Zoetis Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2020 was $6.00M.
- Zoetis Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2017 was -$43.00M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 3 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 9 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | $4.00M 10-K · filed 2025-02-13 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $6.00M 10-K · filed 2021-02-16 | ||
| 2020-09-30 | $6.00M 10-Q · filed 2020-11-05 | |||
| 2017-12-31 | -$43.00M 10-K · filed 2020-02-13 | $43.00M 10-K · filed 2018-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |